- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
Tarrytown Today
By the People, for the People
Mirae Asset Global Investments Boosts Regeneron Pharmaceuticals Holdings
The investment firm increased its stake in the biopharmaceutical company by 23.4% in Q4 2025.
Apr. 17, 2026 at 11:20am
Got story updates? Submit your updates here. ›
Institutional investors like Mirae Asset Global Investments closely monitor and adjust their positions in leading biopharmaceutical companies like Regeneron.Tarrytown TodayMirae Asset Global Investments Co. Ltd. increased its holdings in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) by 23.4% in the fourth quarter, according to a recent SEC filing. The firm now owns 77,204 shares of the biopharmaceutical company's stock, worth $59,591,000.
Why it matters
Regeneron Pharmaceuticals is a leading biopharmaceutical company known for its innovative drug discovery technologies and pipeline of therapies. Institutional investors like Mirae Asset closely monitor and adjust their positions in Regeneron, providing insights into the stock's performance and market sentiment.
The details
Mirae Asset Global Investments purchased an additional 14,635 shares of Regeneron Pharmaceuticals during the fourth quarter, bringing its total stake to 77,204 shares. This represents a 23.4% increase in the firm's holdings of the biopharmaceutical company's stock.
- Mirae Asset Global Investments increased its Regeneron Pharmaceuticals holdings in the fourth quarter of 2025.
- The firm's latest SEC filing disclosing the increased stake was published on April 17, 2026.
The players
Mirae Asset Global Investments Co. Ltd.
A South Korean global asset management firm that has increased its stake in Regeneron Pharmaceuticals.
Regeneron Pharmaceuticals, Inc.
A leading American biopharmaceutical company focused on discovering, developing, and commercializing new medicines.
The takeaway
Mirae Asset's increased investment in Regeneron Pharmaceuticals reflects the firm's confidence in the biopharmaceutical company's growth potential and pipeline of innovative therapies. This move aligns with broader market trends of institutional investors closely monitoring and adjusting their positions in prominent pharmaceutical and biotech stocks.
